What is the management of seizures in a hospital setting?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 3, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Seizures in the Hospital

Administer benzodiazepines immediately as first-line therapy for any actively seizing patient, followed by levetiracetam, fosphenytoin, or valproate as equally effective second-line agents if seizures persist after adequate benzodiazepine dosing. 1, 2

Initial Assessment and Stabilization

Immediate Actions

  • Secure airway, breathing, and circulation—equipment for airway management must be immediately available before administering any antiseizure medications 3
  • Check fingerstick glucose and correct hypoglycemia immediately 2
  • Establish intravenous access and obtain vital signs with continuous cardiac monitoring 4
  • Search for and treat underlying causes including hyponatremia, hypoxia, ischemic stroke, intracerebral hemorrhage, and withdrawal syndromes 2

Status Epilepticus Definition

  • Status epilepticus is defined as a seizure lasting longer than 5 minutes or multiple seizures without return to neurologic baseline 1
  • This is a medical emergency requiring immediate treatment to reduce morbidity and mortality 5

Treatment Algorithm

First-Line: Benzodiazepines

Intravenous Route (Preferred):

  • Lorazepam 4 mg IV slowly (2 mg/min) for adults 3
  • If seizures continue after 10-15 minutes, administer an additional 4 mg IV dose 3
  • Alternative: Diazepam IV if lorazepam unavailable 6

Alternative Routes When IV Access Unavailable:

  • Intramuscular midazolam 10 mg (shown to be non-inferior to IV lorazepam in prehospital studies) 1, 7
  • Rectal diazepam 6
  • Intranasal or buccal midazolam 8, 9

Critical Pitfall: Do NOT use intramuscular diazepam due to erratic absorption 6

Second-Line: Antiseizure Medications (After Benzodiazepine Failure)

All three agents have equivalent efficacy—approximately 45-47% seizure cessation at 60 minutes—so selection should be based on patient-specific contraindications and side effect profiles: 1, 2

Levetiracetam:

  • Dose: 60 mg/kg IV (maximum 4500 mg) over 10 minutes 1
  • Hypotension risk: 0.7% 1, 2
  • Intubation rate: 20% 1
  • Preferred in patients with liver disease or cardiac conduction abnormalities 8

Fosphenytoin:

  • Dose: 20 mg phenytoin equivalents/kg IV at maximum rate of 150 mg/min 4
  • Hypotension risk: 3.2% 1, 2
  • Intubation rate: 26.4% 1
  • Requires continuous cardiac monitoring during infusion 4
  • Avoid in patients with cardiac conduction abnormalities or hypotension 8

Valproate:

  • Dose: 40 mg/kg IV (maximum 3000 mg) over 10 minutes 1
  • Hypotension risk: 1.6% 1, 2
  • Intubation rate: 16.8% 1
  • Contraindicated in pregnancy, liver disease, and mitochondrial disorders 8

Important Note: The patient's home antiseizure medication does not affect the probability of stopping status epilepticus when used as a second-line agent 1, 2

Third-Line: Refractory Status Epilepticus

If seizures persist after adequate first and second-line therapy (refractory status epilepticus), consider: 2

  • Phenobarbital loading dose 2
  • Continuous infusions: propofol, pentobarbital, or midazolam 2
  • Ketamine (emerging evidence supports earlier use) 5, 8

Critical consideration: Pentobarbital has 92% efficacy but 77% of patients require vasopressor support 2

Monitoring and Ongoing Management

EEG Monitoring

  • Consider continuous EEG monitoring for patients with persistent altered consciousness to rule out nonconvulsive status epilepticus 2
  • This is particularly important as transition to nonconvulsive status epilepticus is common 8
  • If patient is not fully awake after apparent seizure cessation, continue EEG for at least 24 hours 8

Medication Administration Details

Phenytoin/Fosphenytoin Specific:

  • Must dilute in normal saline to final concentration ≥5 mg/mL 4
  • Use in-line filter (0.22-0.55 microns) 4
  • Complete infusion within 1-4 hours of preparation 4
  • Maximum rate: 50 mg/min in adults, 1-3 mg/kg/min in pediatrics (whichever is slower) 4

Lorazepam Specific:

  • Contains benzyl alcohol—use caution in neonates 3
  • Maintain patent airway equipment immediately available 3
  • For intramuscular use as preanesthetic: administer at least 2 hours before procedure 3

Common Pitfalls to Avoid

  • Failing to recognize nonconvulsive status epilepticus in patients with persistent altered mental status—obtain EEG 2
  • Not addressing underlying causes while treating the seizure itself (hypoglycemia, hyponatremia, withdrawal, toxins) 2
  • Inadequate benzodiazepine dosing before moving to second-line agents—ensure "optimal dosing" has been achieved 1
  • Using intramuscular diazepam instead of other routes due to erratic absorption 6
  • Delaying treatment to obtain antiseizure medication levels—treat empirically and check levels later 1
  • Administering phenytoin too rapidly without cardiac monitoring—can cause fatal arrhythmias 4
  • Using intramuscular phenytoin for status epilepticus—peak levels may take up to 24 hours 4

Special Considerations

Medication Interactions and Precipitants

  • Prescribed medications (tramadol) and illicit substances (cocaine) can lower seizure threshold 1
  • Noncompliance with antiseizure medications is a common precipitant of ED seizure presentations 1

Disposition

  • Approximately 16-26% of patients with status epilepticus require endotracheal intubation 1, 2
  • Mortality is higher (22.2% vs 6.9%) in patients without prior seizure history who develop status epilepticus 10

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Seizures in the Emergency Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Emergent Management of Status Epilepticus.

Continuum (Minneapolis, Minn.), 2024

Guideline

First-Line Treatment for Occipital Lobe Seizures

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Treatment of Convulsive Status Epilepticus.

Current treatment options in neurology, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.